Drug-induced bladder and urinary disorders - Incidence, prevention and management

被引:51
作者
Drake, MJ [1 ]
Nixon, PM [1 ]
Crew, JP [1 ]
机构
[1] Churchill Hosp, Dept Urol, Oxford OX3 7LJ, England
关键词
D O I
10.2165/00002018-199819010-00004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The bladder is vulnerable to the adverse effects of drugs because of its complex control and the frequent excretion of drug metabolites in the urine, Incontinence results when bladder pressure exceeds sphincter resistance, Stress incontinence because of sphincter weakness occurs with antipsychotics and a-blockers, especially in women, Urge incontinence and irritive symptoms may be caused by drugs. Anticholinergics, anaesthetics and analgesics cause urinary retention because of failure of bladder contraction. They are more likely to cause retention in men because of prostatic enlargement. Cyclophosphamide and tiaprofenic acid can cause chemical cystitis, and should be withdrawn if a patient develops irritative symptoms or haematuria. Cyclophosphamide may also induce bladder tumours. Adverse effects of cyclophosphamide can be reduced with prophylactic administration of mesna and adequate hydration. Mitomycin, doxorubicin or bacillus Calmette-Guerin (BCG) instilled locally to treat bladder tumours can cause cystitis, contracture and calcification. Their administration should be limited to 1 hour per week for a maximum of 8 weeks. Retroperitoneal fibrosis and urine discolouration may be caused by drugs. Ureteric calculi may result from any drug causing nephrolithiasis.
引用
收藏
页码:45 / 55
页数:11
相关论文
共 116 条
[11]   Drug-induced cystitis: The need for vigilance [J].
Bramble, FJ ;
Morley, R .
BRITISH JOURNAL OF UROLOGY, 1997, 79 (01) :3-7
[12]  
BREW JP, 1997, BR J CLIN PRACT, V51, P59
[13]   CYCLOPHOSPHAMIDE-ASSOCIATED CARCINOMA OF UROTHELIUM - MODALITIES FOR PREVENTION [J].
CANNON, J ;
LINKE, CA ;
COS, LR .
UROLOGY, 1991, 38 (05) :413-416
[14]   INCONTINENCE AFTER USE OF ENALAPRIL [J].
CASANOVA, JE .
JOURNAL OF UROLOGY, 1990, 143 (06) :1237-1238
[15]   SPINDLE CELL-CANCER OF BLADDER DURING CYCLOPHOSPHAMIDE THERAPY FOR WEGENER GRANULOMATOSIS [J].
CHASKO, SB ;
KEUHNELIAN, JG ;
GUTOWSKI, WT ;
GRAY, GF .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1980, 4 (02) :191-196
[16]  
COGGINS PR, 1959, CANCER CHEMOTH REP, P9
[17]  
COHEN MAA, 1994, AM J PSYCHIAT, V151, P619
[18]  
*COMM SAF MED, 1989, CURR PROBL JAN, P24
[19]   CYCLOPHOSPHAMIDE CYSTITIS - IDENTIFICATION OF ACROLEIN AS THE CAUSATIVE AGENT [J].
COX, PJ .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (13) :2045-2049
[20]   Severe cystitis associated with tiaprofenic acid [J].
Crawford, MLA ;
Waller, PC ;
Wood, SM .
BRITISH JOURNAL OF UROLOGY, 1997, 79 (04) :578-584